collection
https://read.qxmd.com/read/17273168/aldosterone-impairs-vascular-reactivity-by-decreasing-glucose-6-phosphate-dehydrogenase-activity
#1
COMPARATIVE STUDY
Jane A Leopold, Aamir Dam, Bradley A Maron, Anne W Scribner, Ronglih Liao, Diane E Handy, Robert C Stanton, Bertram Pitt, Joseph Loscalzo
Hyperaldosteronism is associated with impaired vascular reactivity; however, the mechanisms by which aldosterone promotes endothelial dysfunction remain unknown. Glucose-6-phosphate dehydrogenase (G6PD) modulates vascular function by limiting oxidant stress to preserve bioavailable nitric oxide (NO(*)). Here we show that aldosterone (10(-9)-;10(-7) mol/l) decreased endothelial G6PD expression and activity in vitro, resulting in increased oxidant stress and decreased NO(*) levels-similar to what is observed in G6PD-deficient endothelial cells...
February 2007: Nature Medicine
https://read.qxmd.com/read/25398786/endotoxin-and-aki-macrophages-protect-after-preconditioning
#2
EDITORIAL
Karim M Yatim, Martin H Oberbarnscheidt
No abstract text is available yet for this article.
June 2015: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/20054045/preventing-surgical-site-infections-in-nasal-carriers-of-staphylococcus-aureus
#3
RANDOMIZED CONTROLLED TRIAL
Lonneke G M Bode, Jan A J W Kluytmans, Heiman F L Wertheim, Diana Bogaers, Christina M J E Vandenbroucke-Grauls, Robert Roosendaal, Annet Troelstra, Adrienne T A Box, Andreas Voss, Ingeborg van der Tweel, Alex van Belkum, Henri A Verbrugh, Margreet C Vos
BACKGROUND: Nasal carriers of Staphylococcus aureus are at increased risk for health care-associated infections with this organism. Decolonization of nasal and extranasal sites on hospital admission may reduce this risk. METHODS: In a randomized, double-blind, placebo-controlled, multicenter trial, we assessed whether rapid identification of S. aureus nasal carriers by means of a real-time polymerase-chain-reaction (PCR) assay, followed by treatment with mupirocin nasal ointment and chlorhexidine soap, reduces the risk of hospital-associated S...
January 7, 2010: New England Journal of Medicine
https://read.qxmd.com/read/21804539/circulating-urokinase-receptor-as-a-cause-of-focal-segmental-glomerulosclerosis
#4
JOURNAL ARTICLE
Changli Wei, Shafic El Hindi, Jing Li, Alessia Fornoni, Nelson Goes, Junichiro Sageshima, Dony Maiguel, S Ananth Karumanchi, Hui-Kim Yap, Moin Saleem, Qingyin Zhang, Boris Nikolic, Abanti Chaudhuri, Pirouz Daftarian, Eduardo Salido, Armando Torres, Moro Salifu, Minnie M Sarwal, Franz Schaefer, Christian Morath, Vedat Schwenger, Martin Zeier, Vineet Gupta, David Roth, Maria Pia Rastaldi, George Burke, Phillip Ruiz, Jochen Reiser
Focal segmental glomerulosclerosis (FSGS) is a cause of proteinuric kidney disease, compromising both native and transplanted kidneys. Treatment is limited because of a complex pathogenesis, including unknown serum factors. Here we report that serum soluble urokinase receptor (suPAR) is elevated in two-thirds of subjects with primary FSGS, but not in people with other glomerular diseases. We further find that a higher concentration of suPAR before transplantation underlies an increased risk for recurrence of FSGS after transplantation...
July 31, 2011: Nature Medicine
https://read.qxmd.com/read/24873779/risk-stratification-for-in-hospital-mortality-after-heart-transplantation-using-the-modification-of-diet-in-renal-disease-and-the-chronic-kidney-disease-epidemiology-collaboration-equations-for-estimated-glomerular-filtration-rate
#5
JOURNAL ARTICLE
Tajinder P Singh, Michael M Givertz, Kimberlee Gauvreau
BACKGROUND: A new equation for estimating glomerular filtration rate (GFR)-the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation-is better at predicting outcomes in the general population than the Modification of Diet in Renal Disease (MDRD) equation. We compared risk stratification of heart transplant (HT) recipients for early post-HT mortality using estimated GFR from the MDRD and the CKD-EPI equations. METHODS: We identified all patients 18 years or older who underwent their first HT in the United States between January 2007 and October 2010 (n=6,564)...
November 15, 2014: Transplantation
https://read.qxmd.com/read/25364883/cost-effectiveness-of-allopurinol-and-febuxostat-for-the-management-of-gout
#6
JOURNAL ARTICLE
Eric Jutkowitz, Hyon K Choi, Laura T Pizzi, Karen M Kuntz
BACKGROUND: Gout is the most common inflammatory arthritis in the United States. OBJECTIVE: To evaluate the cost-effectiveness of urate-lowering treatment strategies for the management of gout. DESIGN: Markov model. DATA SOURCES: Published literature and expert opinion. TARGET POPULATION: Patients for whom allopurinol or febuxostat is a suitable initial urate-lowering treatment. TIME HORIZON: Lifetime...
November 4, 2014: Annals of Internal Medicine
https://read.qxmd.com/read/25394773/pancreas-transplantation-with-enteroanastomosis-to-native-duodenum-poses-technical-challenges-but-offers-improved-endoscopic-access-for-scheduled-biopsies-and-therapeutic-interventions
#7
JOURNAL ARTICLE
R Horneland, V Paulsen, J P Lindahl, K Grzyb, T J Eide, K Lundin, L Aabakken, T Jenssen, E M Aandahl, A Foss, O Øyen
To facilitate endoscopic access for rejection surveillance and stenting of the pancreas, we have abandoned the duodenojejunostomy (DJ) in favor of duodenoduodenostomy (DD) in pancreas transplantation (PTx). From September 2012 to September 2013 we performed 40 PTx with DD; 20 solitary-PTx (S-PTx) and 20 simultaneous pancreas and kidney transplantation (SPK). We compared the outcomes with results from 40 PTx-DJ (10 S-PTx and 30 SPK) from the preceding era. The DD-enteroanastomoses were performed successfully...
January 2015: American Journal of Transplantation
https://read.qxmd.com/read/25398784/the-macrophage-mediates-the-renoprotective-effects-of-endotoxin-preconditioning
#8
COMPARATIVE STUDY
Takashi Hato, Seth Winfree, Rabih Kalakeche, Shataakshi Dube, Rakesh Kumar, Momoko Yoshimoto, Zoya Plotkin, Pierre C Dagher
Preconditioning is a preventative approach, whereby minimized insults generate protection against subsequent larger exposures to the same or even different insults. In immune cells, endotoxin preconditioning downregulates the inflammatory response and yet, preserves the ability to contain infections. However, the protective mechanisms of preconditioning at the tissue level in organs such as the kidney remain poorly understood. Here, we show that endotoxin preconditioning confers renal epithelial protection in various models of sepsis in vivo...
June 2015: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/25385850/tubular-vascular-endothelial-growth-factor-a-erythropoietin-and-medullary-vessels-a-trio-linked-by-hypoxia
#9
EDITORIAL
Alda Tufro
No abstract text is available yet for this article.
May 2015: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/25385849/tubulovascular-cross-talk-by-vascular-endothelial-growth-factor-a-maintains-peritubular-microvasculature-in-kidney
#10
JOURNAL ARTICLE
Henrik Dimke, Matthew A Sparks, Benjamin R Thomson, Sebastian Frische, Thomas M Coffman, Susan E Quaggin
Vascular endothelial growth factor A (VEGFA) production by podocytes is critical for glomerular endothelial health. VEGFA is also expressed in tubular epithelial cells in kidney; however, its physiologic role in the tubule has not been established. Using targeted transgenic mouse models, we found that Vegfa is expressed by specific epithelial cells along the nephron, whereas expression of its receptor (Kdr/Vegfr2) is largely restricted to adjacent peritubular capillaries. Embryonic deletion of tubular Vegfa did not affect systemic Vegfa levels, whereas renal Vegfa abundance was markedly decreased...
May 2015: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/17890258/hepatorenal-syndrome-current-diagnostic-and-therapeutic-concepts
#11
REVIEW
Michael Schepke
No abstract text is available yet for this article.
September 2007: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/25378589/haemodialysis-adequacy-monitoring-for-phosphate-an-old-problem-with-new-solutions
#12
COMMENT
Carlo Basile, Daniel Schneditz
No abstract text is available yet for this article.
January 2015: Nephrology, Dialysis, Transplantation
https://read.qxmd.com/read/19608703/bicarbonate-supplementation-slows-progression-of-ckd-and-improves-nutritional-status
#13
RANDOMIZED CONTROLLED TRIAL
Ione de Brito-Ashurst, Mira Varagunam, Martin J Raftery, Muhammad M Yaqoob
Bicarbonate supplementation preserves renal function in experimental chronic kidney disease (CKD), but whether the same benefit occurs in humans is unknown. Here, we randomly assigned 134 adult patients with CKD (creatinine clearance [CrCl] 15 to 30 ml/min per 1.73 m(2)) and serum bicarbonate 16 to 20 mmol/L to either supplementation with oral sodium bicarbonate or standard care for 2 yr. The primary end points were rate of CrCl decline, the proportion of patients with rapid decline of CrCl (>3 ml/min per 1...
September 2009: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/24795142/antimicrobial-prophylaxis-for-children-with-vesicoureteral-reflux
#14
RANDOMIZED CONTROLLED TRIAL
Alejandro Hoberman, Saul P Greenfield, Tej K Mattoo, Ron Keren, Ranjiv Mathews, Hans G Pohl, Bradley P Kropp, Steven J Skoog, Caleb P Nelson, Marva Moxey-Mims, Russell W Chesney, Myra A Carpenter
BACKGROUND: Children with febrile urinary tract infection commonly have vesicoureteral reflux. Because trial results have been limited and inconsistent, the use of antimicrobial prophylaxis to prevent recurrences in children with reflux remains controversial. METHODS: In this 2-year, multisite, randomized, placebo-controlled trial involving 607 children with vesicoureteral reflux that was diagnosed after a first or second febrile or symptomatic urinary tract infection, we evaluated the efficacy of trimethoprim-sulfamethoxazole prophylaxis in preventing recurrences (primary outcome)...
June 19, 2014: New England Journal of Medicine
https://read.qxmd.com/read/24694986/treatment-of-metabolic-acidosis-in-patients-with-stage-3-chronic-kidney-disease-with-fruits-and-vegetables-or-oral-bicarbonate-reduces-urine-angiotensinogen-and-preserves-glomerular-filtration-rate
#15
RANDOMIZED CONTROLLED TRIAL
Nimrit Goraya, Jan Simoni, Chan-Hee Jo, Donald E Wesson
Alkali therapy of metabolic acidosis in patients with chronic kidney disease (CKD) with plasma total CO2 (TCO2) below 22 mmol/l per KDOQI guidelines appears to preserve estimated glomerular filtration rate (eGFR). Since angiotensin II mediates GFR decline in partial nephrectomy models of CKD and even mild metabolic acidosis increases kidney angiotensin II in animals, alkali treatment of CKD-related metabolic acidosis in patients with plasma TCO2 over 22 mmol/l might preserve GFR through reduced kidney angiotensin II...
November 2014: Kidney International
https://read.qxmd.com/read/24751169/echocardiography-in-hemodialysis-patients-uses-and-challenges
#16
REVIEW
Diana Y Y Chiu, Darren Green, Nik Abidin, Smeeta Sinha, Philip A Kalra
Patients with end-stage renal disease undergoing hemodialysis have high rates of morbidity and mortality. Cardiovascular disease accounts for almost half of this mortality, with the single most common cause being sudden cardiac death. Early detection of abnormalities in cardiac structure and function may be important to allow timely and appropriate cardiac interventions. Echocardiography is noninvasive cardiac imaging that is widely available and provides invaluable information on cardiac morphology and function...
November 2014: American Journal of Kidney Diseases
https://read.qxmd.com/read/19907042/revascularization-versus-medical-therapy-for-renal-artery-stenosis
#17
RANDOMIZED CONTROLLED TRIAL
Keith Wheatley, Natalie Ives, Richard Gray, Philip A Kalra, Jonathan G Moss, Colin Baigent, Susan Carr, Nicholas Chalmers, David Eadington, George Hamilton, Graham Lipkin, Anthony Nicholson, John Scoble
BACKGROUND: Percutaneous revascularization of the renal arteries improves patency in atherosclerotic renovascular disease, yet evidence of a clinical benefit is limited. METHODS: In a randomized, unblinded trial, we assigned 806 patients with atherosclerotic renovascular disease either to undergo revascularization in addition to receiving medical therapy or to receive medical therapy alone. The primary outcome was renal function, as measured by the reciprocal of the serum creatinine level (a measure that has a linear relationship with creatinine clearance)...
November 12, 2009: New England Journal of Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.